SCHEMBL8398255

SCHEMBL8398255

CCOC(=O)c1cncnc1NN

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 1/20 0.46
AGTR2 P50052 1/20 0.46
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 6/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HSP90AA1 P07900 1/20 0.43
TSHR P16473 1/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 2/20 0.42
HSD17B10 Q99714 2/20 0.41
FOS P01100 2/20 0.41
JUN P05412 2/20 0.41
NFKB1 P19838 2/20 0.41
NFKB2 Q00653 2/20 0.41
RELA Q04206 2/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 1/20 0.41
TP53 P04637 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1961297 0.84 AGTR1 (0.45) AGTR1AGTR2KDM4EALDH1A1MEN1
SCHEMBL19453361 0.84 AGTR1 (0.47) AGTR1AGTR2KDM4EALDH1A1MEN1
SCHEMBL11584008 0.80 AGTR1 (0.43) AGTR1AGTR2KDM4EALDH1A1MEN1
SCHEMBL1964549 0.80 RAB9A (0.52) KDM4EALDH1A1MEN1KMT2AHSP90AA1
SCHEMBL11584012 0.79 AGTR1 (0.47) AGTR1AGTR2KDM4EALDH1A1MEN1
SCHEMBL29906642 0.79 TSHR (0.48) KDM4EALDH1A1MEN1KMT2AHSP90AA1
SCHEMBL1669584 0.79 TSHR (0.48) KDM4EALDH1A1MEN1KMT2AHSP90AA1
SCHEMBL24933235 0.78 NR2F2 (0.56) KDM4EALDH1A1MEN1KMT2ANPC1
SCHEMBL15170632 0.78 LMNA (0.45) AGTR1AGTR2KDM4EALDH1A1HSP90AA1
SCHEMBL30240878 0.78 NR2F2 (0.56) KDM4EALDH1A1MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5935966-A COMPOUNDS THAT BLOCK THE ACTIVATION OF TRANSCRIPTION FACTORS THROUGH INHIBITION OF A FAMILY OF SPECIFIC KINASES, DECREASING PROINFLAMMATORY PROTEINS TO TREAT AUTOIMMUNE DISEASES AND AS GENERAL ANTIINFLAMMATORY AGENTS SIGNAL PHARMACEUTICALS, INC. (US) 1999-08-10 US disclosed
WO-1998038171-A1 PYRIMIDINE CARBOXYLATES AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1998-09-03 WO disclosed
WO-1997009325-A1 PYRIMIDINE CARBOXYLATES AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1997-03-13 WO disclosed